A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy
From MaRDI portal
Publication:1758078
DOI10.1007/S11538-012-9722-4zbMath1251.92023OpenAlexW2163228402WikidataQ37293334 ScholiaQ37293334MaRDI QIDQ1758078
Publication date: 7 November 2012
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc3822329
Probabilistic models, generic numerical methods in probability and statistics (65C20) Medical applications (general) (92C50)
Related Items (35)
Mathematical modeling of tumor and cancer stem cells treated with CAR-T therapy and inhibition of TGF-\(\beta\) ⋮ Is the Allee effect relevant in cancer evolution and therapy? ⋮ A cancer treatment based on synergy between anti-angiogenic and immune cell therapies ⋮ A mathematical prognosis model for pancreatic cancer patients receiving immunotherapy ⋮ A mathematical model for pancreatic cancer growth and treatments ⋮ Combination therapies and intra-tumoral competition: insights from mathematical modeling ⋮ Existence of periodic solution for a tumor growth model with vaccine interaction ⋮ An optimal control problem of immuno-chemotherapy in presence of gene therapy ⋮ Ultimate dynamics of the Kirschner-Panetta model: tumor eradication and related problems ⋮ A mathematical model of treatment of cancer stem cells with immunotherapy ⋮ A tumor-Immune interaction model with the effect of impulse therapy ⋮ Modeling the role of immune cell conversion in the tumor-immune microenvironment ⋮ Understanding the interplay of CAR-NK cells and triple-negative breast cancer: insights from computational modeling ⋮ Mathematical analysis on a diffusion model describing the compatibility between two types of tumor cells ⋮ Mathematical modelling of the inhibitory role of regulatory T cells in tumor immune response ⋮ A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies ⋮ A MATHEMATICAL MODEL OF PANCREATIC CANCER WITH TWO KINDS OF TREATMENTS ⋮ Analysis of tumour-immune evasion with chemo-immuno therapeutic treatment with quadratic optimal control ⋮ A structural methodology for modeling immune-tumor interactions including pro- and anti-tumor factors for clinical applications ⋮ A minimal model of T cell avidity may identify subtherapeutic vaccine schedules ⋮ Optimal control of variable-order fractional model for delay cancer treatments ⋮ Dependence of CD8 T cell response upon antigen load during primary infection. ⋮ Optimization of combination therapy for chronic myeloid leukemia with dosing constraints ⋮ Mathematical modeling, analysis, and simulation of tumor dynamics with drug interventions ⋮ Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells ⋮ Modeling the stem cell hypothesis: investigating the effects of cancer stem cells and TGF \(- \beta\) on tumor growth ⋮ Mathematics + Cancer: An Undergraduate "Bridge" Course in Applied Mathematics ⋮ MATHEMATICAL MODELING OF PANCREATIC CANCER TREATMENT WITH CANCER STEM CELLS ⋮ Therapy strategy in tumour cells and immune system interaction mathematical model ⋮ Algorithmic asymptotic analysis: extending the arsenal of cancer immunology modeling ⋮ Effects of mutations and immunogenicity on outcomes of anti-cancer therapies for secondary lesions ⋮ Efficiency of cancer treatments: in silico experiments ⋮ Dynamics of breast cancer under different rates of chemoradiotherapy ⋮ Analysis of stochastic dynamics of tumor with drug interventions ⋮ Optimal control for cancer treatment mathematical model using Atangana-Baleanu-Caputo fractional derivative
Cites Work
- Optimal control in a model of dendritic cell transfection cancer immunotherapy
- A mathematical model quantifies proliferation and motility effects of TGF-\(\beta\) on cancer cells
- A mathematical model for single cell cancer\,--\, immune system dynamics
- Emergent group dynamics governed by regulatory cells produce a robust primary T cell response
- Modeling immunotherapy of the tumor -- immune interaction
- Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
- The role of growth factors in avascular tumour growth
- A mathematical model of tumor-immune evasion and siRNA treatment
- Interactions between the immune system and cancer: A brief review of non-spatial mathematical models
- A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences
- Cellular Immunotherapy for High Grade Gliomas: Mathematical Analysis Deriving Efficacious Infusion Rates Based on Patient Requirements
This page was built for publication: A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy
